• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

依托泊苷治疗后发生的继发性白血病涉及混合谱系白血病基因重排

[Secondary leukemia after etoposide treatment involved MLL gene rearrangement].

作者信息

Iida H, Taji H, Iida M, Suzuki R, Sugihara T, Minami S, Kodera Y, Yamamoto K, Seto M, Ueda R

机构信息

Department of Internal Medicine, Japan Red Cross Nagoya First Hospital.

出版信息

Rinsho Ketsueki. 1994 Jun;35(6):569-75.

PMID:8078192
Abstract

The 11q23 chromosomal abnormality is frequently observed in infantile leukemia and secondary leukemia, and the translocation associated gene in infantile leukemia is called mixed-lineage leukemia (MLL) gene. A 50-year-old man was admitted because of left axillary lymphadenopathy and IBL like T cell lymphoma was diagnosed by lymph node biopsy. The patient responded to the LSG-9 protocol with complete remission. After 10 months he was readmitted because of fever and was diagnosed acute myeloblastic leukemia by bone marrow aspiration. Chromosome analysis revealed 11q23 abnormality, suggesting that the leukemia was induced by etoposide treatment. Southern blot analysis demonstrated DNA rearrangement in the MLL gene at 11q23. It was suggested that the breakpoint region of the MLL gene in secondary leukemia is the same as that of infantile leukemia.

摘要

11q23染色体异常在婴儿白血病和继发性白血病中经常可见,婴儿白血病中的易位相关基因被称为混合谱系白血病(MLL)基因。一名50岁男性因左腋窝淋巴结病入院,经淋巴结活检诊断为间变性大细胞淋巴瘤(IBL)样T细胞淋巴瘤。该患者对LSG-9方案有反应,达到完全缓解。10个月后,他因发热再次入院,经骨髓穿刺诊断为急性髓细胞白血病。染色体分析显示11q23异常,提示白血病是由依托泊苷治疗诱发的。Southern印迹分析表明11q23处的MLL基因发生了DNA重排。提示继发性白血病中MLL基因的断裂点区域与婴儿白血病相同。

相似文献

1
[Secondary leukemia after etoposide treatment involved MLL gene rearrangement].依托泊苷治疗后发生的继发性白血病涉及混合谱系白血病基因重排
Rinsho Ketsueki. 1994 Jun;35(6):569-75.
2
Acute myelomonocytic leukemia after treatment with chronic oral etoposide: are MLL and LTG9 genes targets for etoposide?慢性口服依托泊苷治疗后发生的急性粒单核细胞白血病:MLL和LTG9基因是依托泊苷的作用靶点吗?
Int J Hematol. 1994 Aug;60(2):145-9.
3
11q23 abnormalities in patients with acute myelogenous leukemia and myelodysplastic syndrome as detected by molecular and cytogenetic analyses.通过分子和细胞遗传学分析检测急性髓性白血病和骨髓增生异常综合征患者的11q23异常。
Am J Clin Pathol. 2000 Nov;114(5):793-7. doi: 10.1309/XY44-L8TE-PWU5-62MP.
4
[Rearrangements of the mixed lineage leukemia gene in acute myeloid leukemia].[急性髓系白血病中混合谱系白血病基因的重排]
Zhonghua Yi Xue Za Zhi. 2006 Aug 29;86(32):2256-60.
5
A case of infantile acute lymphoblastic leukemia presenting with rearrangement of MLL at 11q23 and apparent insertion or translocation at 10p12.1例婴儿急性淋巴细胞白血病,伴有11q23处MLL重排及10p12处明显插入或易位。
Cancer Genet Cytogenet. 2004 Oct 1;154(1):57-9. doi: 10.1016/j.cancergencyto.2004.01.018.
6
Common region of ALL-1 gene disrupted in epipodophyllotoxin-related secondary acute myeloid leukemia.在鬼臼毒素相关的继发性急性髓系白血病中被破坏的ALL-1基因的共同区域。
Cancer Res. 1993 Jul 1;53(13):2954-6.
7
[Clinical significance and frequency of the 11q23/MLL genetic molecular alteration in Chilean infants with acute leukemia].[智利急性白血病婴儿中11q23/MLL基因分子改变的临床意义及频率]
Rev Med Chil. 2001 Jun;129(6):634-42.
8
Therapy-related acute lymphoblastic leukemia without 11q23 abnormality: report of six cases and a literature review.伴 11q23 异常之外的治疗相关性急性淋巴细胞白血病:六例报告及文献复习。
Am J Clin Pathol. 2010 Jan;133(1):75-82. doi: 10.1309/AJCPYWC6AQC7BAVJ.
9
The inv(11)(p15q22) chromosome translocation of therapy-related myelodysplasia with NUP98-DDX10 and DDX10-NUP98 fusion transcripts.伴有NUP98-DDX10和DDX10-NUP98融合转录本的治疗相关骨髓增生异常综合征的inv(11)(p15q22)染色体易位
Int J Hematol. 1999 Apr;69(3):160-4.
10
A new chromosomal three-way rearrangement involving MLL masked by a t(9;19)(p11;p13) in an infant with acute myeloid leukemia.一名患有急性髓系白血病的婴儿中,一种涉及MLL的新的染色体三向重排被t(9;19)(p11;p13)掩盖。
Cancer Genet Cytogenet. 2009 Feb;189(1):59-62. doi: 10.1016/j.cancergencyto.2008.10.009.